Insights from 2023 ESMO Annual Meeting

 

Genitourinary
09:09

Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "PSMA PET-Directed Outcomes in mHSPC: Implications for the STAMPEDE2 Trial Design"

FEATURING Hoda Abdel-Aty
  • 90 views
  • January 12, 2024
03:01

Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Prognostic Role of Metastatic Site in Patients With De Novo Metastatic Prostate Cancer - A Population-Based Analysis in New Hormonal Agents Era"

FEATURING Emre Yekedüz
  • 68 views
  • January 12, 2024
08:30

Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Association of Health-Related Quality of Life with Efficacy Outcomes in the VISION Study of Patients With mCRPC"

FEATURING Michael Morris
  • 45 views
  • December 28, 2023
05:58

Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Vascular Fingerprint Tool to Identify Testicular Cancer Pts at High-Risk for Early Cardiovascular Events After Cisplatin-Based Chemotherapy"

FEATURING Andrea Meuleman
  • 19 views
  • December 27, 2023
05:29

Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Real-World OS With Enzalutamide & Abiraterone Acetate in Patients With Chemotherapy-Naïve mCRPC"

FEATURING Daniel George
  • 101 views
  • December 5, 2023
03:52

Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "ARASENS Trial - PSA Outcomes With Darolutamide, ADT, and Docetaxel in Patients With High- and Low-Volume mHSPC"

FEATURING Fred Saad
  • 103 views
  • November 30, 2023
  • 1
31:30

Insights from 2023 ESMO Annual Meeting

ESMO23 Highlights in Urothelial Carcinoma

FEATURING Guru Sonpavde, Bradley McGregor
  • 232 views
  • November 28, 2023
  • 1
08:35

Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "The BonEnza Study - Changes in Bone Mineral Density, Trabecular Bone Score, and Body Composition in mHSPC Patients Randomized to Receive ADT+Enzalutamide+/-Zoledronic Acid"

FEATURING Alberto Dalla Volta
  • 77 views
  • November 28, 2023
  • 1
08:56

Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "MEDI5752 (Volrustomig) in the 1L Treatment of Patients With Advanced ccRCC"

FEATURING Martin Voss
  • 124 views
  • November 24, 2023
08:26

Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Efficacy & Safety Outcomes With Pembro Rechallenge for Patients With Advanced/Metastatic Urothelial Cancer Who Responded to First-Course Treatment"

FEATURING Vadim Koshkin
  • 180 views
  • November 15, 2023
  • 1
11:53

Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Bladder Preservation Strategies - A Surgeon’s Perspective on Organ Preservation for Refractory NMIBC"

FEATURING Joost Boormans
  • 80 views
  • November 10, 2023
  • 1
04:48

Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "EMBARK Secondary Endpoints - Enzalutamide Monotherapy for the Treatment of Prostate Cancer With High-Risk Biochemical Recurrence"

FEATURING Ugo De Giorgi
  • 267 views
  • November 9, 2023
  • 3
14:06

Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "The DAD Trial - SG+EV as ≥ 2L Therapy for mUC"

FEATURING Bradley McGregor
  • 167 views
  • November 6, 2023
09:35

Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "State-of-the-Art in Adjuvant Treatment of RCC"

FEATURING Guillermo de Velasco
  • 293 views
  • November 3, 2023
  • 3
10:48

Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "[177 Lu]Lu-PSMA-617 in Taxane-Naïve Patients With mCRPC (PSMAfore)"

FEATURING Oliver Sartor
  • 335 views
  • November 3, 2023
  • 1
13:49

Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "THOR Study - Erdafitinib vs. Pembrolizumab in Pretreated Patients With Advanced/Metastatic Urothelial Cancer With Select FGFR Alterations"

FEATURING Arlene Siefker-Radtke
  • 165 views
  • November 3, 2023
06:25

Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "The Tide-A Study - Avelumab + Intermittent Axitinib in Previously Untreated Patients With mRCC"

FEATURING Roberto Iacovelli
  • 87 views
  • November 3, 2023
  • 1
06:22

Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "CABASTY Trial - Pain Response and HRQL Analysis in Patients With mCRPC Receiving Cabazitaxel Every 2 Weeks vs. Every 3 Weeks"

FEATURING Stéphane Oudard
  • 108 views
  • November 3, 2023
05:59

Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "EV-302/KEYNOTE-A39 Study of Enfortumab Vedotin + Pembro vs. Chemo in Previously Untreated la/mUC"

FEATURING Thomas Powles
  • 285 views
  • October 30, 2023
  • 2
22:19

Insights from 2023 ESMO Annual Meeting

Bladder Cancer Highlights From ESMO 2023: Comparing and Contrasting EV302 and CheckMate 901

FEATURING Guru Sonpavde
  • 835 views
  • October 30, 2023
  • 2
03:49

Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Effect of Rapid Ultra-Low Prostate-Specific Antigen Decline in TITAN Patients With mCSPC Who Received Apalutamide + ADT"

FEATURING Axel Merseburger
  • 446 views
  • October 30, 2023
  • 2
06:52

Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Androgen Receptor Pathway Inhibitors or Taxanes for Patients With mCRPC - A Direct Comparison in ProBio, a Randomized, Outcome-Adaptive, Biomarker-Driven Platform Trial"

FEATURING Henrik Grönberg
  • 77 views
  • October 30, 2023
  • 1
04:59

Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Post Hoc Analysis of the CLEAR Trial - Tumor Response by Baseline Metastases in Patients With RCC Treated With Lenvatinib + Pembro vs. Sunitinib"

FEATURING Viktor Grünwald
  • 109 views
  • October 25, 2023
10:12

Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Phase 3 Randomized EMBARK Study - Enzalutamide/Placebo + Leuprolide Acetate and Enzalutamide Monotherapy in High-Risk Biochemically Recurrent Prostate Cancer"

FEATURING Stephen Freedland
  • 496 views
  • October 25, 2023
  • 4
07:53

Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "LITESPARK-005 Study - Belzutifan vs. Everolimus in Participants With Previously Treated Advanced ccRCC"

FEATURING Laurence Albiges
  • 137 views
  • October 25, 2023